Sibley D R, Benovic J L, Caron M G, Lefkowitz R J
Howard Hughes Medical Institute, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.
Adv Exp Med Biol. 1987;221:253-73. doi: 10.1007/978-1-4684-7618-7_19.
Multiple mechanisms seem to be involved in regulating the responsiveness of hormone receptor-coupled adenylate cyclase systems. These mechanisms at least involve the receptors and nucleotide regulatory proteins. With the recent development of methods for purifying the catalytic unit of the enzyme it will be possible to assess whether it is also a locus for such regulatory phenomena. At least two major pathways of receptor regulation have been uncovered. Homologous desensitization (Fig. 9) involves the uncoupling and translocation of the receptors out of their normal plasma membrane environment. This process sequesters the receptors away from their effector, the regulatory and catalytic components of adenylate cyclase. The site of receptor sequestration is unclear and might lie within the plasma membrane or within the cell. The sequestered receptors can recycle to the cell surface or become down-regulated, perhaps being destroyed within the cell. Phosphorylation of the receptors through a beta-adrenergic receptor kinase appears to be associated with homologous desensitization. This phosphorylation event may serve either to uncouple functionally the receptors or to trigger their sequestration from the cell surface or both. In heterologous desensitization (Fig. 10), receptor function is regulated by phosphorylation in the absence of receptor sequestration or down-regulation. This covalent modification serves to functionally uncouple the receptors, that is, to impair their interactions with the guanine nucleotide regulatory proteins. Several protein kinases seem to be capable of promoting phosphorylation of the receptors including the cAMP-dependent kinase and protein kinase C. In addition to the receptor modification, heterologous desensitization seems to be associated with functional modifications (phosphorylation?) at the level of nucleotide regulatory proteins (Ns and Ni), (Fig. 10). Further studies of the mechanisms of desensitization of adenylate cyclase-coupled receptors are thus likely to help elucidate modes of regulation of a wide variety of receptor-coupled functions in diverse types of cells.
多种机制似乎参与调节激素受体偶联的腺苷酸环化酶系统的反应性。这些机制至少涉及受体和核苷酸调节蛋白。随着纯化该酶催化单位方法的最新进展,将有可能评估它是否也是这种调节现象的一个位点。至少已发现了两条主要的受体调节途径。同源脱敏(图9)涉及受体从其正常的质膜环境中解偶联和易位。这个过程将受体与它们的效应器——腺苷酸环化酶的调节和催化成分隔离开来。受体隔离的位点尚不清楚,可能位于质膜内或细胞内。被隔离的受体可以循环回到细胞表面或被下调,也许会在细胞内被破坏。通过β-肾上腺素能受体激酶对受体进行磷酸化似乎与同源脱敏有关。这种磷酸化事件可能要么在功能上使受体解偶联,要么触发它们从细胞表面被隔离,或者两者兼而有之。在异源脱敏(图10)中,受体功能在没有受体隔离或下调的情况下通过磷酸化来调节。这种共价修饰在功能上使受体解偶联,也就是说,损害它们与鸟嘌呤核苷酸调节蛋白的相互作用。几种蛋白激酶似乎都能够促进受体的磷酸化,包括cAMP依赖性激酶和蛋白激酶C。除了受体修饰外,异源脱敏似乎还与核苷酸调节蛋白(Ns和Ni)水平的功能修饰(磷酸化?)有关(图10)。因此,对腺苷酸环化酶偶联受体脱敏机制的进一步研究可能有助于阐明多种类型细胞中各种受体偶联功能的调节模式。